Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Vistagen Therapeutics Inc (NQ: VTGN ) 2.960 -0.040 (-1.33%) Streaming Delayed Price Updated: 9:36 AM EDT, Oct 3, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 3,606 Open 2.990 Bid (Size) 2.970 (20) Ask (Size) 2.990 (2) Prev. Close 3.000 Today's Range 2.960 - 3.010 52wk Range 2.450 - 5.860 Shares Outstanding 9,362,444 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Vistagen Initiates PALISADE-4 Phase 3 Study of Fasedienol for the Acute Treatment of Social Anxiety Disorder September 23, 2024 From Vistagen Via Business Wire BioMedNewsBreaks — Vistagen Therapeutics Inc. (NASDAQ: VTGN) Releases Q1 2025 Financial, Corporate Report August 14, 2024 Via Investor Brand Network Performance YTD -42.52% -42.52% 1 Month -11.90% -11.90% 3 Month -10.57% -10.57% 6 Month -44.98% -44.98% 1 Year -23.42% -23.42% More News Read More VTGN Stock Earnings: VistaGen Therapeutics Beats EPS, Misses Revenue for Q1 2025 August 13, 2024 Via InvestorPlace Vistagen Reports Fiscal Year 2025 First Quarter Financial Results and Corporate Update August 13, 2024 From Vistagen Via Business Wire InvestorNewsBreaks – Vistagen Therapeutics Inc. (NASDAQ: VTGN) Schedules Release of Q1 2025 Results, Conference Call August 06, 2024 Via Investor Brand Network Vistagen to Report Fiscal Year 2025 First Quarter Results and Host Corporate Update Conference Call on August 13, 2024 August 06, 2024 From Vistagen Via Business Wire 3 Stocks Under $15 That Could Make You a Millionaire July 26, 2024 Via InvestorPlace InvestorNewsBreaks – Vistagen Therapeutics Inc. (NASDAQ: VTGN) Awarded New Patents from Four Countries to Broaden Global PH80 IP Portfolio July 09, 2024 Via Investor Brand Network Topics Intellectual Property Exposures Intellectual Property Vistagen Broadens PH80 Global Intellectual Property Portfolio with New Patents for the Treatment of Migraine July 09, 2024 From Vistagen Via Business Wire InvestorNewsBreaks – Vistagen Therapeutics Inc. (NASDAQ: VTGN) Receives Mental Health America’s Highest Honor June 27, 2024 Via Investor Brand Network Vistagen Awarded Mental Health America’s Platinum Bell Seal for Workplace Mental Health for the Second Consecutive Year June 27, 2024 From Vistagen Via Business Wire TinyGemsBreaks – Vistagen Therapeutics Inc. (NASDAQ: VTGN) Releases FY 2024 Financial Report, Corporate Update June 12, 2024 Via Investor Brand Network VTGN Stock Earnings: VistaGen Therapeutics Beats EPS, Misses Revenue for Q4 2024 June 12, 2024 Via InvestorPlace Vistagen Reports Fiscal Year 2024 Financial Results and Provides Corporate Update June 11, 2024 From Vistagen Via Business Wire BioMedNewsBreaks — Vistagen Therapeutics Inc. (NASDAQ: VTGN) Schedules FY 2024 Financial Results Report, Conference Call June 07, 2024 Via Investor Brand Network Vistagen to Report Fiscal Year 2024 Financial Results and Host Corporate Update Conference Call on June 11, 2024 June 07, 2024 From Vistagen Via Business Wire TinyGemsBreaks – Vistagen Therapeutics Inc. (NASDAQ: VTGN) CEO to Present at Jefferies Global Healthcare Conference May 29, 2024 Via Investor Brand Network Vistagen to Present at the Jefferies Global Healthcare Conference May 29, 2024 From Vistagen Via Business Wire BioMedNewsBreaks — Vistagen Therapeutics Inc. (NASDAQ: VTGN) to Present Posters at Upcoming ASCP Conference May 23, 2024 Via Investor Brand Network Vistagen to Present at the 2024 American Society of Clinical Psychopharmacology (ASCP) Conference May 23, 2024 From Vistagen Via Business Wire 3 Must-Have Penny Stocks to Boost Your 2024 Portfolio May 14, 2024 Via InvestorPlace Meme Stock Rebound: 3 Reddit Favorites Primed for a Resurgence May 13, 2024 Via InvestorPlace InvestorNewsBreaks – Vistagen Therapeutics Inc. (NASDAQ: VTGN) to Present at Upcoming RBC Capital Markets Global Healthcare Conference May 07, 2024 Via Investor Brand Network Vistagen to Present at the 2024 RBC Capital Markets Global Healthcare Conference May 07, 2024 From Vistagen Via Business Wire InvestorNewsBreaks – Vistagen Therapeutics Inc. (NASDAQ: VTGN) Reports Positive PH15 Data from Pilot Study Showing Psychomotor Impairment Improvement April 25, 2024 Via Investor Brand Network Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.